Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Alnylam Pharmaceuticals, Inc.
About ALNY
Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR) in adults ; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Zilebesiran, Elebsiran, Mivelsiran, ALN-6400, and ALN-HTT02. It is developing Cemdisiran to treat complement-mediated diseases.
Find out what a historical investment in Alnylam Pharmaceuticals, Inc. would be worth today using our ALNY stock calculator.
Market Capitalisation
$39.85B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
214.03K
High today
$301.28
Low today
$293.00
Open price
$296.64
52-week high
$495.55
52-week low
$284.19
Ready to start your investing journey with Stake?
Open an accountHow do I buy ALNY shares in Australia?
Buying ALNY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Alnylam Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ALNY
What is the ticker symbol of Alnylam Pharmaceuticals, Inc.?
The ticker symbol for Alnylam Pharmaceuticals, Inc. is ALNY.
How much is one share of ALNY?
One share of ALNY is valued at $301.09 as of 21 May 2026.
What is the market capitalisation of Alnylam Pharmaceuticals, Inc. ALNY?
As of 21 May 2026 Alnylam Pharmaceuticals, Inc. has a market cap of $39.85B.
What is the P/E ratio of ALNY?
The Price to Earnings ratio of ALNY is 71.09.
What is the Earnings Per Share of ALNY?
The Earnings Per Share of ALNY is $4.20.
What is the 52-week high for Alnylam Pharmaceuticals, Inc. stock?
The Alnylam Pharmaceuticals, Inc. 52-week high stock price is $495.55.
What is the 52-week low for Alnylam Pharmaceuticals, Inc. stock?
The Alnylam Pharmaceuticals, Inc. 52-week low stock price is $284.19.
Can I buy ALNY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ALNY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ALNY on Stake
- Buy ALNY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ALNY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ALNY related stocks